| Financial Year |
March 31 2023 |
| Monetary Funds |
4,570,087,366.08 |
| Held-for-trading Financial Assets |
3,208,489,689.44 |
| Notes Receivable |
-- |
| Accounts Receivable |
230,362,389.78 |
| Advances to Suppliers |
31,153,021.73 |
| Other Receivables |
64,499,033.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,920.81 |
| Dividend Receivable |
-- |
| Inventories |
761,393,695.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,678,021.81 |
| Other Current Assets |
129,134,913.62 |
| Total Current Assets |
9,005,174,880.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
5,651,812,756.50 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
823,226,045.33 |
| R&D expenses |
-- |
| Goodwill |
62,148,847.81 |
| Long-Term Deferred and Prepaid Expenses |
1,216,752,181.03 |
| Deferred Income Tax Assets |
748,528,422.44 |
| Other Non-Current Assets |
763,555,294.92 |
| Sub-Total of Non-Current Assets |
20,004,611,575.19 |
| Total Assets |
29,009,786,455.47 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,845,772,947.50 |
| Accounts Received In Advance |
174,309,055.64 |
| Employee Compensation Payable |
172,095,541.22 |
| Taxes Payable |
115,342,513.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,273,751,853.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,358,782,551.66 |
| Other Current Liabilities |
427,645,914.78 |
| Sub-Total of Current Liabilities |
10,610,902,615.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
239,438,909.10 |
| Other Non-Current Liabilities |
1,352,000,000.00 |
| Sub-Total of Non-Current Liabilities |
14,141,128,930.29 |
| Total Liabilities |
24,752,031,546.27 |
| Paid-In Capital(Or Share Stock) |
1,168,847,750.00 |
| Capital Surplus |
1,139,040,730.82 |
| Surplus Reserve |
569,384,204.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,373,529,277.76 |
| Minority Stockholder's Interest |
6,722,952.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,251,031,957.16 |
| Owner's Equity（Stockholder's Equity） |
4,257,754,909.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
29,009,786,455.47 |
